comparemela.com

Latest Breaking News On - Tae kyu - Page 1 : comparemela.com

iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that it has completed the efficacy evaluation study of BAL200, a novel.

United statesSoult ukpyolsiSouth koreaSang hyeonKyonggi doNtron biotechnology incBd teamTae kyu tk bd team leaderInhalational anthraxOrphan drug designationPost exposure prophylaxisAnimal efficacy ruleAnimal ruleKyung wonVice presidentTae kyu

iNtRON is finalizing the SAL200 Tech Transfer

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that the Tech Transfer process of SAL200, endolysin-based new.

United statesSoult ukpyolsiSouth koreaKyonggi doSang hyeonGyeonggi doRepublic of koreaNtron biotechnology incIntodeworld incBd teamTae kyu tk bd team leaderTech transferKyung wonVice presidentTae kyuIntron biotechnology

iNtRON developed advanced bacteriophage engineering platform technology based on modified random mutagenesis

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that the Company has established the 2nd generation technology of.

United statesSoult ukpyolsiSouth koreaKyonggi doGyeonggi doRepublic of koreaJee sooNtron biotechnology incIntodeworld incBd teamTae kyu tk bd team leaderRobot bacteriophageMcas systemHigh throughput screeningKyung wonVice president

iNtRON completes the sponsorship transfer process for the US Phase 2 study of SAL200

iNtRON completes the sponsorship transfer process for the US Phase 2 study of SAL200

United statesSoult ukpyolsiSouth koreaKyonggi doGyeonggi doRepublic of koreaNtron biotechnology incIntodeworld incBd teamTae kyu tk bd team leaderUs centerKyung wonAntimicrobial resistanceDisease controlBig pharmaVice president

iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) announced today that iNtRON has developed its unique CRISPR/Cas system customized for the.

United statesSoult ukpyolsiSouth koreaKyonggi doGyeonggi doRepublic of koreaJee sooNtron biotechnology incIntodeworld incBd teamTae kyu tk bd team leaderBio drug businessKyung wonVice presidentTae kyuIntron biotechnology

vimarsana © 2020. All Rights Reserved.